Drug profile · INN
propafenone hydrochloride
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride (PROPAFENONE HYDROCHLORIDE) is a beta-1 adrenergic receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — propafenone hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
propafenone hydrochloride (PROPAFENONE HYDROCHLORIDE) is a beta-1 adrenergic receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-1 adrenergic receptor antagonist
Primary target: Beta-1 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is propafenone hydrochloride?
propafenone hydrochloride (PROPAFENONE HYDROCHLORIDE) is a beta-1 adrenergic receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for propafenone hydrochloride?
PROPAFENONE HYDROCHLORIDE is a marketed brand name for propafenone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of propafenone hydrochloride?
propafenone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.